The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
Open accessAbstract
N -arachidonoylethanolamine (anandamide) was the first endogenous cannabinoid receptor ligand to be discovered. Dual synthetic pathways for anandamide have been proposed. One is the formation from free arachidonic acid and ethanolamine, and the other is the formation from N -arachidonoyl phosphatidylethanolamine (PE) through the action of a phosphodiesterase. These pathways, however, do not appear to be able to generate a large amount of anandamide, at least under physiological conditions. The generation of anandamide from free arachidonic acid and ethanolamine is catalyzed by a degrading enzyme anandamide amidohydrolase/fatty acid amide hydrolase operating in reverse and requires large amounts of substrates. As for the second pathway, arachidonic acids esterified at the 1-position of glycerophospholipids, which are mostly esterified at the 2-position, are utilized for the formation of N -arachidonoyl PE, a stored precursor form of anandamide. In fact, the actual levels of anandamide in various tissues are generally low except in a few cases. 2-Arachidonoylglycerol (2-AG) was the second endogenous cannabinoid receptor ligand to be discovered. 2-AG is a degradation product of arachidonic acid-containing glycerophospholipids such as inositol phospholipids. Several investigators have demonstrated that 2-AG is produced in a variety of tissues and cells upon stimulation. 2-AG acts as a full agonist at the cannabinoid receptors (CB1 and CB2). Evidence is gradually accumulating and indicates that 2-AG is the most efficacious endogenous natural ligand for the cannabinoid receptors. In this review, we summarize the tissue levels, biosynthesis, degradation and possible physiological significance of two endogenous cannabimimetic molecules, anandamide and 2-AG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Self-citationVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Leptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Self-citationA second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Regulation of Phosphoinositide-specific Phospholipase C Isozymes
Rhee, S. G., & Bae, Y. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15045 · Cited by 876
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 775
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Diglyceride lipase: a pathway for arachidonate release from human platelets.
Bell, R. L., Kennerly, D. A., Stanford, N., & Majerus, P. W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3238 · Cited by 687
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Shen, M., Piser, T. M., Seybold, V. S., & Thayer, S. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04322.1996 · Cited by 604
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Williams, C. M., & Kirkham, T. C. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 505
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 485
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
N-Acylated glycerophospholipids and their derivatives
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1990) · Progress in Lipid Research · doi:10.1016/0163-7827(90)90004-5 · Cited by 451
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 451
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429
Mechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
De Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8375 · Cited by 413
Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410
Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2
Yu, M., Ives, D., & Ramesha, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21181 · Cited by 404
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 393
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Smith, P. B., Compton, D. R., Welch, S. P., Razdan, R. K., Mechoulam, R., & Martin, B. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22356-4 · Cited by 393
Kozak, K. R., Rowlinson, S. W., & Marnett, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007088200 · Cited by 390
Endocannabinoids control spasticity in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0399fje · Cited by 378
Dewey, W. L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90061-4 · Cited by 375
Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., & Waku, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.605 · Cited by 371
Self-citationGonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., & Di Marzo, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 369
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 362
Production and physiological actions of anandamide in the vasculature of the rat kidney.
Deutsch, D. G., Goligorsky, M. S., Schmid, P. C., Krebsbach, R. J., Schmid, H. H., Das, S. K., Dey, S. K., Arreaza, G., Thorup, C., Stefano, G., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119677 · Cited by 360
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Venance, L., Piomelli, D., Glowinski, J., & Glaume, C. (1995) · Nature · doi:10.1038/376590a0 · Cited by 352
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005722200 · Cited by 347
Anandamide Amidohydrolase Activity in Rat Brain Microsomes
Desarnaud, F., Cadas, H., & Piomelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6030 · Cited by 336
Functional CB1 cannabinoid receptors in human vascular endothelial cells
Liu, J., Gao, B., Mirshahi, F., Sanyal, A. J., Khanolkar, A. D., Makriyannis, A., & Kunos, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460835 · Cited by 333
Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
Goparaju, S. K., Ueda, N., Yamaguchi, H., & Yamamoto, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01603-7 · Cited by 328
Felder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., Koppel, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 326
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
Cadas, H., Gaillet, S., Beltramo, M., Venance, L., & Piomelli, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03934.1996 · Cited by 319
Prescott, S. M., & Majerus, P. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33114-4 · Cited by 315
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
Maingret, F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.47 · Cited by 313
Di Marzo, V. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00042-3 · Cited by 312
Bisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernandez-Ruiz, J. J., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 312
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 310
Self-citationGebremedhin, D., Lange, A. R., Campbell, W. B., Hillard, C. J., & Harder, D. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2085 · Cited by 308
Ueda, N., Kurahashi, Y., Yamamoto, S., & Tokunaga, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23823 · Cited by 303
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., & Mechoulam, R. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03576.x · Cited by 300
Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Berrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V., & Fern�ndez-Ruiz, J. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990901)33:3<181::aid-syn3>3.0.co;2-r · Cited by 289
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 284
BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., PETROCELLIS, L. D., & MARZO, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 275
Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V. (2000) · Endocrinology · doi:10.1210/endo.141.1.7239 · Cited by 265
Schmid, P. C., Paria, B. C., Krebsbach, R. J., Schmid, H. H. O., & Dey, S. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4188 · Cited by 264
An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant
Randall, M. D., Alexander, S. P. H., Bennett, T., Boyd, E. A., Fry, J. R., Gardiner, S. M., Kemp, P. A., Mcculloch, A. I., & Kendall, D. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1766 · Cited by 261
The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
Wagner, J. A., Varga, K., Járai, Z., & Kunos, G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.429 · Cited by 257
Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 254
Berger, A., Crozier, G., Bisogno, T., Cavaliere, P., Innis, S., & Di Marzo, V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101119098 · Cited by 247
Guan, X., Cravatt, B. F., Ehring, G. R., Hall, J. E., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1785 · Cited by 242
Vaughan, C. W., Connor, M., Bagley, E. E., & Christie, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23200-4 · Cited by 241
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703850 · Cited by 237
Essential fatty acids and eicosanoids
Goodacre, R. (1993) · Endeavour · doi:10.1016/0160-9327(93)90078-h · Cited by 237
2-Arachidonoylglycerol and the cannabinoid receptors
Sugiura, T., & Waku, K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00189-4 · Cited by 235
Self-citationSchmid, P. C., Krebsbach, R. J., Perry, S. R., Dettmer, T. M., Maasson, J. L., & Schmid, H. H. O. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01194-j · Cited by 235
Hillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233
Schmid, P. C., Reddy, P. V., Natarajan, V, & Schmid, H. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44667-9 · Cited by 232
Crawley, J. N., Corwin, R. L., Robinson, J. K., Felder, C. C., Devane, W. A., & Axelrod, J. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90230-q · Cited by 231
Beltramo, M., & Piomelli, D. (2000) · NeuroReport · doi:10.1097/00001756-200004270-00018 · Cited by 230
Hao, S., Avraham, Y., Mechoulam, R., & Berry, E. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00059-5 · Cited by 229
N-Acylethanolamines and precursor phospholipids — relation to cell injury
Hansen, H. S., Moesgaard, B., Hansen, H. H., & Petersen, G. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00192-4 · Cited by 222
Devane, W. A., & Axelrod, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6698 · Cited by 220
Bidirectional control of airway responsiveness by endogenous cannabinoids
Calignano, A., Kátona, I., Désarnaud, F., Giuffrida, A., La Rana, G., Mackie, K., Freund, T. F., & Piomelli, D. (2000) · Nature · doi:10.1038/35040576 · Cited by 217
Goparaju, S., Ueda, N., Taniguchi, K., & Yamamoto, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00314-1 · Cited by 213
Straiker, A., Stella, N., Piomelli, D., Mackie, K., Karten, H. J., & Maguire, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14565 · Cited by 211
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., Ishima, Y., & Waku, K. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0053h.x · Cited by 211
Self-citationThe peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 210
Terranova, J.-P., Michaud, J.-C., Le Fur, G., & Soubrié, P. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00169393 · Cited by 206
The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase
Deutsch, D. G., Glaser, S. T., Howell, J. M., Kunz, J. S., Puffenbarger, R. A., Hillard, C. J., & Abumrad, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003161200 · Cited by 206
Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 201
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
Varga, K., Lake, K., Martin, B. R., & Kunos, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00181-j · Cited by 201
De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G. D., Creminon, C., Davis, J. B., Geppetti, P., & Di Marzo, V. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00406.x · Cited by 200
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve-Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23114-x · Cited by 200
MARZO, V. D., BISOGNO, T., SUGIURA, T., MELCK, D., & PETROCELLIS, L. D. (1998) · Biochemical Journal · doi:10.1042/bj3310015 · Cited by 199
Self-citationMaurelli, S., Bisogno, T., De Petrocellis, L., Di Luccia, A., Marino, G., & Di Marzo, V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01311-3 · Cited by 199
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 197
Self-citationAnandamide Hydrolysis by Human Cells in Culture and Brain
Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G. A., Vliegenthart, J. F. G., & Agrò, A. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32332 · Cited by 197
Properties of rat liver N-acylethanolamine amidohydrolase.
Schmid, P. C., Zuzarte-Augustin, M. L., & Schmid, H. H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38695-7 · Cited by 197
Di MARZO, V., De PETROCELLIS, L., SEPE, N., & BUONO, A. (1996) · Biochemical Journal · doi:10.1042/bj3160977 · Cited by 196
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake, K. D., Compton, D. M., Varga, K., Martin, B. R., & Kunos, G. (1997) · PubMed · Cited by 195
Tognetto, M., Amadesi, S., Harrison, S., Creminon, C., Trevisani, M., Carreras, M., Matera, M., Geppetti, P., & Bianchi, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01104.2001 · Cited by 195
Stefano, G. B., Liu, Y., & Goligorsky, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19238 · Cited by 185
Breivogel, C. S., Selley, D. E., & Childers, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16865 · Cited by 185
Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
Derkinderen, P., Toutant, M., Burgaya, F., Le Bert, M., Siciliano, J. C., de Franciscis, V., Gelman, M., & Girault, J.-A. (1996) · Science · doi:10.1126/science.273.5282.1719 · Cited by 180
Carayon, P., Marchand, J., Dussossoy, D., Derocq, J.-M., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 178
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats
Sinor, A. D., Irvin, S. M., & Greenberg, D. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00922-2 · Cited by 174
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
De Petrocellis, L., Melck, D., Bisogno, T., & Di Marzo, V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00196-1 · Cited by 173
The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide
Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., & Davis, R. J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00027-7 · Cited by 173
Schuel, H., Goldstein, E., Mechoulam, R., Zimmerman, A. M., & Zimmerman, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7678 · Cited by 172
Melck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzmán, M., & Di Marzo, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01639-7 · Cited by 168
Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 168
Di Marzo, V., Berrendero, F., Bisogno, T., González, S., Cavaliere, P., Romero, J., Cebeira, M., Ramos, J. A., & Fernández‐Ruiz, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741627.x · Cited by 168
Cannabinoids enhance human B‐cell growth at low nanomolar concentrations
Derocq, J.-M., Ségui, M., Marchand, J., Le Fur, G., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 167
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00170-4 · Cited by 167
Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1757 · Cited by 164
Self-citationQuantification of Bioactive Acylethanolamides in Rat Plasma by Electrospray Mass Spectrometry
Giuffrida, A., Rodríguez de Fonseca, F., & Piomelli, D. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4509 · Cited by 164
Gallily, R., Breuer, A., & Mechoulam, R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00653-1 · Cited by 163
Bisogno, T., Melck, D., De Petrocellis, L., & Di Marzo, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
The uptake by cells of 2‐arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi‐Agrò, A., Hillard, C., & Di Marzo, V. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02072.x · Cited by 160
McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35147-x · Cited by 160
Cannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampus
Derkinderen, P., Ledent, C., Parmentier, M., & Girault, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00333.x · Cited by 159
Endogenous Cannabinoid Signaling
Piomelli, D., Beltramo, M., Giuffrida, A., & Stella, N. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0221 · Cited by 159
Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?
Schmid, H. H. O. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00188-2 · Cited by 157
Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium
Epps, D. E. V., Natarajan, V., Schmid, P. C., & Schmid, H. H. O. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90260-x · Cited by 154
Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3
Sarker, K. P., Obara, S., Nakata, M., Kitajima, I., & Maruyama, I. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01425-3 · Cited by 153
Mechanism of the Hypotensive Action of Anandamide in Anesthetized Rats
Varga, K., Lake, K. D., Huangfu, D., Guyenet, P. G., & Kunos, G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.682 · Cited by 151
Kondo, S., Kondo, H., Nakane, S., Kodaka, T., Tokumura, A., Waku, K., & Sugiura, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00581-x · Cited by 147
Self-citationBasavarajappa, B. S., & Hungund, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720522.x · Cited by 145
N-acylethanolamine accumulation in infarcted myocardium
Epps, D. E. V., Schmid, P. C., Natarajan, V., & Schmid, H. H. O. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91281-6 · Cited by 145
Sugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., & Waku, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8187 · Cited by 144
Self-citationN-acylation of ethanolamine phospholipids in canine myocardium
Natarajan, V., Reddy, P. V., Schmid, P. C., & Schmid, H. H. O. (1982) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(82)90352-6 · Cited by 140
Lee, M., Yang, K. H., & Kaminski, N. E. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12097-1 · Cited by 136
Pagotto, U., Marsicano, G., Fezza, F., Theodoropoulou, M., Grübler, Y., Stalla, J., Arzberger, T., Milone, A., Losa, M., Marzo, V. D., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7565 · Cited by 133
Bisogno, T., Delton-v, I., Milone, A., Lagarde, M., & Marzo, V. D. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1410 · Cited by 132
Hampson, A. J., Hill, W. A. G., Zan-Phillips, M., Makriyannis, A., Leung, E., Eglen, R. M., & Bornheim, L. M. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00157-8 · Cited by 131
Basavarajappa, B. S., Saito, M., Cooper, T. B., & Hungund, B. L. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00085-5 · Cited by 131
Trick or treat from food endocannabinoids?
Marzo, V. D., Sepe, N., PETROCELLIS, L. D., Berger, A., Crozier, G. L., Fride, E., & Mechoulam, R. (1998) · Nature · doi:10.1038/25267 · Cited by 130
Wang, Y., Liu, Y., Ito, Y., Hashiguchi, T., Kitajima, I., Yamakuchi, M., Shimizu, H., Matsuo, S., Imaizumi, H., & Maruyama, I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5015 · Cited by 130
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404
Giuffrida, A., de Fonseca, F. R., Nava, F. A., Loubet‐Lescoulié, P., & Piomelli, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00786-x · Cited by 130
Boger, D. L., Patterson, J. E., Guan, X., Cravatt, B. F., Lerner, R. A., & Gilula, N. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4810 · Cited by 130
Sugiura, T., Kodaka, T., Kondo, S., et al. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021838 · Cited by 129
Self-citationDistribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
Katayama, K., Ueda, N., Kurahashi, Y., Suzuki, H., Yamamoto, S., & Kato, I. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00078-7 · Cited by 128
Oláh, Z., Karai, L., & Iadarola, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101607200 · Cited by 127
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
Plane, F., Holland, M., Waldron, G. J., Garland, C. J., & Boyle, J. P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701361 · Cited by 125
Kearn, C. S., Greenberg, M. J., DiCamelli, R. F., Kurzawa, K., & Hillard, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722379.x · Cited by 122
Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Kruszka, K. K., & Gross, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36624-3 · Cited by 115
Hasegawa‐Sasaki, H. (1985) · Biochemical Journal · doi:10.1042/bj2320099 · Cited by 115
N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brain
Natarajan, V., Schmid, P. C., & Schmid, H. H. O. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90341-3 · Cited by 114
Kempe, K. C., Hsu, F., Bohrer, A., & TURK, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17287 · Cited by 114
Paria, B. C., Ma, W., Andrenyak, D. M., Schmid, P. C., Schmid, H. H. O., Moody, D. E., Deng, H., Makriyannis, A., & Dey, S. K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.6.1490 · Cited by 113
Anandamide suppresses nitric oxide and TNF-α responses to Theilerʼs virus or endotoxin in astrocytes
Molina‐Holgado, F., Lledó, A., & Guaza, C. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00027 · Cited by 110
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system
Pestonjamasp, V. K., & BURSTEIN, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00110-6 · Cited by 110
Mechoulam, R., Fride, E., Ben‐Shabat, S., Meiri, U., & Horowitz, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00777-8 · Cited by 107
Kimura, T., Ohta, T., Watanabe, K., et al. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.224 · Cited by 106
Molina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 106
Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 105
Pratt, P. F., Hillard, C. J., Edgemond, W. S., & Campbell, W. B. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.1.h375 · Cited by 105
Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice
Járai, Z., Wagner, J. A., Goparaju, S. K., Wang, L., Razdan, R. K., Sugiura, T., Zimmer, A. M., Bonner, T. I., Zimmer, A. D., & Kunos, G. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.679 · Cited by 105
Self-citationFimiani, C., Mattocks, D. A. L., Cavani, F., Salzet, M., Deutsch, D. G., Pryor, S. C., Bilfinger, T. V., & Stefano, G. B. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00060-6 · Cited by 104
Gammon, C. M., Allen, A. C., & Morell, P. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07299.x · Cited by 104
An acid amidase hydrolyzing anandamide as an endogenous ligand forcannabinoid receptors
Ueda, N., Yamanaka, K., Terasawa, Y., & Yamamoto, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00820-0 · Cited by 103
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 102
Ouyang, Y., Hwang, S. G., Han, S. H., & Kaminski, N. E. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.676 · Cited by 101
Sugiura, T., Nakane, S., Kishimoto, S., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00127-4 · Cited by 98
Self-citationHansen, H. S., Lauritzen, L., Strand, A. M., Moesgaard, B., & Frandsen, A. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00134-x · Cited by 98
Maccarrone, M., Attinà, M., Cartoni, A., Bari, M., & Finazzi‐Agrò, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00092.x · Cited by 98
Hansen, H. H., Ikonomidou, C., Bittigau, P., Hansen, S. H., & Hansen, H. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00006.x · Cited by 97
Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells
Berdyshev, E. V., Schmid, P. C., Dong, Z., & Schmid, H. H. O. (2000) · Biochemical Journal · doi:10.1042/bj3460369 · Cited by 97
Potentiation of anandamide hypotension by the transport inhibitor, AM404
Calignano, A., Rana, G. L., Beltramo, M., Makriyannis, A., & Piomelli, D. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01297-1 · Cited by 96
Biosynthesis of N‐Acylethanolamine Phospholipids by Dog Brain Preparations
Natarajan, V., Schmid, P. C., Reddy, P. V., Zuzarte‐Augustin, M. L., & Schmid, H. H. O. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00825.x · Cited by 96
Marzo, V. D., PETROCELLIS, L. D., Sugiura, T., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1501 · Cited by 96
Self-citationBisogno, T., Katayama, K., Melck, D. J., Ueda, N., PETROCELLIS, L. D., Yamamoto, S., & Marzo, V. D. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540634.x · Cited by 95
Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland
González, S. R., Manzanares, J., Berrendero, F., Wenger, T., Corchero, J., Bisogno, T., Romero, J., Fuentes, J. A., Marzo, V. D., Ramos, J. A., et al. (1999) · Neuroendocrinology · doi:10.1159/000054468 · Cited by 93
Stefano, G. B., Salzet, M., Magazine, H. I., & Bilfinger, T. V. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199806000-00003 · Cited by 93
Pagotto, U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2687 · Cited by 93
Kondo, S., Sugiura, T., Kodaka, T., Kudo, N., Waku, K., & Tokumura, A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0688 · Cited by 92
Self-citationRelative efficacies of cannabinoid CB1 receptor agonists in the mouse brain
Burkey, T. H., Quock, R. M., Consroe, P. F., Ehlert, F. J., Hosohata, Y., Roeske, W. R., & Yamamura, H. I. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01255-7 · Cited by 91
Prévot, V., Rialas, C. M., Croix, D., Salzet, M., Dupouy, J., Poulain, P., Beauvillain, J., & Stefano, G. B. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00066-3 · Cited by 89
Kurahashi, Y., Ueda, N., Suzuki, H., Suzuki, M., & Yamamoto, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7180 · Cited by 89
Selective Oxygenation of the Endocannabinoid 2-Arachidonylglycerol by Leukocyte-Type 12-Lipoxygenase
Moody, J. S., Kozak, K. R., Ji, C., & Marnett, L. J. (2000) · Biochemistry · doi:10.1021/bi002303b · Cited by 88
Konrad, R. J., Major, C. D., & Wolf, B. A. (1994) · Biochemistry · doi:10.1021/bi00249a015 · Cited by 88
Hansen, H. S., Lauritzen, L., Strand, A. M., Vinggaard, A. M., Frandsen, A., & Schousboe, A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020753.x · Cited by 88
Marzo, V. D., PETROCELLIS, L. D., Bisogno, T., & Melck, D. J. (1999) · Lipids · doi:10.1007/bf02562332 · Cited by 87
Koga, D., Santa, T., Fukushima, T., Homma, H., & Imai, K. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00391-x · Cited by 85
Moesgaard, B., Petersen, G. L., Jaroszewski, J. W., & Hansen, H. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32041-1 · Cited by 80
Anandamide‐induced mobilization of cytosolic Ca 2+ in endothelial cells
Mombouli, J., Schaeffer, G., Holzmann, S., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702483 · Cited by 78
N‐acylphosphatidylethanolamine‐hydrolysing phospholipase D lacks the ability to transphosphatidylate
Petersen, G. L., & Hansen, H. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00861-3 · Cited by 78
Schmid, P. C., Schwartz, K. D., Smith, C. N., Krebsbach, R. J., Berdyshev, E. V., & Schmid, H. H. O. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(99)00124-3 · Cited by 78
Derocq, J., Bouaboula, M., Marchand, J., Rinaldi, M. L., Ségui, M., & Casellas, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00275-0 · Cited by 77
Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.
Fride, E., Barg, J., Levy, R., Saya, D., Heldman, E., Mechoulam, R., & Vogel, Z. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24465-2 · Cited by 75
Shivachar, A. C., Martin, B. R., & Ellis, E. F. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02248-1 · Cited by 74
Johnson, D. E., Heald, S. L., Dally, R. D., et al. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90048-2 · Cited by 74
Kobayashi, Y., Arai, S., Waku, K., & Sugiura, T. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002904 · Cited by 74
Self-citationChen, Y., McCarron, R. M., Ohara, Y., Bembry, J., Azzam, N. A., Lenz, F. A., Shohami, E., Mechoulam, R., & Spatz, M. (2000) · Circulation Research · doi:10.1161/01.res.87.4.323 · Cited by 71
Sugiura, T., Kodaka, T., Kondo, S., Tonegawa, T., Nakane, S., Kishimoto, S., Yamashita, A., & Waku, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6425 · Cited by 71
Self-citation
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Metadata
- Authors
- Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K.
- Venue
- Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 66
- Issue
- 2-3
- Pages
- 173-192
- ISSN
- 0952-3278 (ISSN-L)
- OpenAlex
- W2061306380
- Cited by
- 348
- References
- 230
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.